We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CANF market cap is 13.6M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 197k | 196k | 196k | 196k | 155k |
| Operating Income | -3.08M | -2.71M | -1.78M | -1.87M | -1.83M |
| Net Income | -3.02M | -2.55M | -1.67M | -1.76M | -1.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.03M | 763k | 853k | 810k | 743k |
| Operating Income | -12.01M | -14.14M | -12.84M | -10.1M | -8.2M |
| Net Income | -12.63M | -15.16M | -15.21M | -10.17M | -7.63M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.28M | 13.49M | 11.03M | 9.17M | 9.99M |
| Total Liabilities | 4.81M | 5M | 4.16M | 3.93M | 3.75M |
| Total Equity | 4.47M | 8.49M | 6.87M | 5.24M | 6.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.17M | 9.52M | 20.25M | 9.28M | 9.99M |
| Total Liabilities | 5.73M | 3.45M | 5.87M | 4.81M | 3.75M |
| Total Equity | 2.44M | 6.07M | 14.38M | 4.47M | 6.24M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.8M | N/A | -5.05M | N/A | -8.44M |
| Investing | 9.5M | N/A | -1M | N/A | 498k |
| Financing | N/A | N/A | 6.53M | N/A | 9.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.83M | -12.06M | -9.86M | -10.8M | -8.44M |
| Investing | -253k | -26k | -14.51M | 9.5M | 498k |
| Financing | 10.17M | 17.68M | 20.46M | N/A | 9.14M |
| Market Cap | 13.6M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 4.53M |
| Average Volume (1 week) | 111.75k |
| Average Volume (1 Month) | 132.58k |
| 52 Week Change | -0.66% |
| 52 Week High | 4.48 |
| 52 Week Low | 1.81 |
| Spread (Intraday) | 0.26 (8.41%) |
| Company Name | Can Fite BioPharma Ltd |
| Address |
10 bareket street petah tikva, center 4951778 |
| Website | https://www.canfite.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
